Clinical Trial Update: Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of Rufinamide for chronic post-thoracotomy pain syndrome was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury
• Post-thoracotomy Pain Syndrome

Drugs mentioned

• Rufinamide (Rufinamide)

Snippet

Sponsor: University of Zurich | Conditions: Peripheral Nerve Injuries, Pain | Phase 2 | Status: WITHDRAWN